Related references
Note: Only part of the references are listed.Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
Truc Sophia Dinh et al.
FRONTIERS IN PHARMACOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Adverse drug reactions associated with amitriptyline - protocol for a systematic multiple-indication review and meta-analysis
Maria-Sophie Brueckle et al.
SYSTEMATIC REVIEWS (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Randomized double-blind controlled study of bedtime low-dose amitriptyline in chronic neck pain
J. Maarrawi et al.
EUROPEAN JOURNAL OF PAIN (2018)
Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis
X. -M. Xu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
The prescribing cascade revisited
Paula A. Rochon et al.
LANCET (2017)
Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data
Joshua Niznik et al.
DRUGS & AGING (2017)
Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines' levels of anticholinergic activity and clinical indications
P. J. Magin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
Andre Leite Goncalves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
Shannon L. Risacher et al.
JAMA NEUROLOGY (2016)
Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence
Agnese Collamati et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis
Kimberley Ruxton et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study
Nicholas J. Talley et al.
GASTROENTEROLOGY (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy
Natalya Dinat et al.
PLOS ONE (2015)
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
CAC Coupland et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review
Yen-Fu Chen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Placebo and Nocebo Effects in Randomized Controlled Trials: The Implications for Research and Practice
Christine Sanderson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
James R. Couch
HEADACHE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Could It Be Better to Discard 90% of the Data? A Statistical Paradox
T. D. Stanley et al.
AMERICAN STATISTICIAN (2010)
Effect of Amitriptyline on Symptoms in Treatment Naive Patients With Interstitial Cystitis/Painful Bladder Syndrome
Harris E. Foster et al.
JOURNAL OF UROLOGY (2010)
Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use
Rose H. Goldman et al.
PAIN (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Clarification of terminology in drug safety
JK Aronson et al.
DRUG SAFETY (2005)
The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system -: A randomised placebo-controlled study on healthy volunteers
J Penttilä et al.
PSYCHOPHARMACOLOGY (2001)
Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas
JPA Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Anticholinergic side-effects of drugs in elderly people
J Mintzer et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2000)
Share Paper
